Single-Use Bioreactors Market to be dominated by Stirred tank SUB through 2028
The
growing advancement in bioprocessing technology is expected to drive the growth
of Global Single-Use Bioreactors Market in the forecast period, 2024-2028.
According
to TechSci Research report, “Single-Use Bioreactors Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global
Single-Use Bioreactors Market is anticipated to grow at an impressive rate in
the forecast period, 2024-2028. This can be ascribed to the growing
awareness about the applications of bioreactors in pharmaceutical and
biotechnology for biopharmaceutical manufacturing for novel drugs. Growing
research and development for new drugs and vaccines in the pharmaceutical
company as well as research institutes are propelling the growth of the market
during the forecast period. Also, the high demand for rapid development of
vaccines, enzymes, antibodies, and hormones combined with increased product
qualities are propelling the growth of the market during the forecast period.
However, Quality control issues such
as leachable and extractables from plastic components and concerns over
contamination risk pose a challenge to the adoption of single-use bioreactors
which may restrain the growth of the market during the forecast period.
Similarly, higher operating costs and limited compatibility with certain
processes may restrict the growth of the market during the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Single-Use Bioreactors Market”
The Global Single-Use Bioreactors Market can be segmented based on
product, type, type of cell, molecule, application, usage, end user, and
region.
Based on the type, the Global Single-Use Bioreactors Market can be
segmented into stirred tank SUB, wave induced SUB, bubble column SUB, and other
SUB. The
stirred tank SUB segment dominated the market in 2022 and is expected to
continue maintaining its dominance throughout the forecast period. This can be
ascribed to the growing demand for their advantages over traditional
stainless-steel bioreactors, such as reduced contamination risks, lower capital
investment, improved flexibility, and scalability. Also, the increasing demand
for production of monoclonal antibodies, vaccines, and cell and gene therapies
for diagnosis of chronic diseases will further drive the growth of the market
over the years.
Based on
end user, the market can be differentiated into pharmaceutical and
biopharmaceutical companies, CROSs & CMOS, academic and research institutes. The pharmaceutical and
biopharmaceutical companies’ segment is expected to dominate during the
forecast period on account of the increasing demand for bioprocessing
technologies in academic research and development for drug discovery. Also,
Advances in bioprocessing technology, such as the development of high-density
cell cultures and continuous manufacturing processes, are driving the demand
for single-use bioreactors.
Major companies operating in the global Single-Use Bioreactors market
are:
- ABEC,INC.
- Able
Corporation & Biott Corporation.
- BBI-Biotech
Gmbh.
- Cellexus
Biosystems PLC.
- Celltainer
Biotech BV.
- Danaher
Corp.
- Distek Inc.
- Eppendorf
AG.
- G&G
Technologies, Inc.
- Getinge AB.
Recent Developments:
- In December 2022, Merck
acquired Erbi Biosystems, a Massachusetts-based company to develop a 2ml micro
bioreactor platform, Breez. The deal strengthened Merck’s upstream portfolio in
the therapeutic protein segment.
- In June 2022, Exothera SA
partnered with Polyplus-transfection SA and Logic Bio Therapeutics to produce a
scalable AAV manufacturing platform. The allegro stirred tank single-use
bioreactors produced by Pall Corporation have been selected for this project.
- In 2021, Thermofisher
launched a new bioreactor which produces 3,000 and 5,000L single-use
bioreactors for commercial and clinical batches.
- In May 2022, RD-Biotech, a
Contract Research Organization (CRO) specializing in the production of plasmid
DNA (pDNA) for early-phase clinical trials partnered with Pall Corporation to
supply single-use solutions and purification technology to support the
manufacture of industrially relevant volumes of GMP-grade pDNA.
- In March,2020, Sartorius
launched BIOSTAT STR Generation 3 with BIOBRAIN—making biopharmaceutical
development and production faster, simpler, and safer.
- In 2019, Pall Corporation
partnered with Freeline to implement the iCELLis bioreactor system in
Freeline’s adeno-associated virus (AAV) manufacturing platform. This
partnership aims to achieve commercial scale and quality production of AAV gene
therapy vectors.
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“North America is expected to dominate the Global Single-Use Bioreactors
Market on account due to the presence of major biopharmaceutical companies,
increasing R&D activities, and favorable regulatory environment across the
region. Similarly, the increasingly well-established regulatory framework that
supports the development and commercialization of biopharmaceutical products is
expected to drive the growth of the market in the forecast periods. Also,
increasing well-developed healthcare infrastructure and many biopharmaceutical
companies in the region are anticipated to drive the growth of the market in
the forecast period. Besides, the increasing demand for novel drugs for the
treatment of chronic diseases and increasing demand for quality checking of the
drugs, it is further expected to create lucrative opportunities for market
growth” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based global management consulting firm.
“Single-Use Bioreactors Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Single use bioreactor
systems, Single use media bags, Single use filtration assemblies, other
products), By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB,
Other SUB), By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other
Cells), By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem
Cells, Other molecules), By Application (Research and Development,
Bioproduction), By Usage (Lab scale production, Pilot scale production, large
scale production), By End User (Pharmaceutical and Biopharmaceutical companies,
CROSs & CMOS, Academic and Research Institutes), By Region and Competition”, has evaluated the
future growth potential of global Single-Use Bioreactors market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision-makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the Global Single-Use Bioreactors market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com